bioRxivCancer BiologyPreprint
Air plasma-activated medium exerts tumor-specific cytotoxicity via the oxidative stress-induced perinuclear mitochondrial clustering
M. Suzuki-Karasaki, T. Ando, Y. Ochiai, K. Kawahara, M. Suzuki-Karasaki, H. Nakayama, Y. Suzuki-Karasaki
Abstract
Intractable cancers such as osteosarcoma (OS) and oral cancer (OC) are highly refractory, recurrent, and metastatic once developed, and their prognosis is still disappointing. Tumor-targeted therapy eliminating cancers effectively and safely is the current clinical choice. Since aggressive tumors have inherent or acquired resistance to multidisciplinary therapies targeting apoptosis, tumor-specific induction of another cell death modality is a promising avenue to meet the goal. Here, we report that a cold atmospheric air plasma-activated medium (APAM) can induce cell death in OS and OC via a unique mitochondrial clustering. This event was named monopolar perinuclear mitochondrial clustering (MPMC) because of the characteristic unipolar mitochondrial perinuclear aggregation. APAM had potent antitumor activity both in vitro and in vivo. APAM caused apoptosis, necrotic cell death, and autophagy. APAM contained hydrogen peroxide and increased mitochondrial ROS (mROS), while the antioxidant N-acetylcysteine (NAC) prevented cell death. MPMC occurred following mitochondrial fragmentation coinciding with nuclear damages. MPMC was accompanied by the tubulin network remodeling and mitochondrial lipid peroxide (mLPO) accumulation and prevented by NAC and the microtubule inhibitor, Nocodazole. Increased Cardiolipin (CL) oxidation was also seen, and NAC and the peroxy radical scavenger Ferrostatin-1 prevented it. In contrast, in fibroblasts, APAM induced minimal cell death, mROS generation, mLPO accumulation, CL oxidation, and MPMC. These results suggest that MPMC is a tumor-specific cause of cell death via mitochondrial oxidative stress and microtubule-driven mitochondrial motility. MPMC might serve as a promising target for exerting tumor-specific cytotoxicity. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/466636v1_ufig1.gif" ALT="Figure 1"> View larger version (20K): org.highwire.dtl.DTLVardef@1118e2corg.highwire.dtl.DTLVardef@18cf99corg.highwire.dtl.DTLVardef@57a7edorg.highwire.dtl.DTLVardef@d1f447_HPS_FORMAT_FIGEXP M_FIG Graphical abstract C_FIG
- organism: human
- assay: proteomics
- assay: metabolomics
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ozone mediates tumor-selective cell death caused by air plasma-activated medium independently of NOx
Y. Suzuki-Karasaki, M. Suzuki-Karasaki, … H. Nakayama·bioRxiv·Mar 17, 2023
- Synergistic anticancer effect of plasma-activated infusion and salinomycin by targeting autophagy and mitochondrial morphology
T. Andou, M. Suzuki-Karasaki, … Y. Suzuki-Karasaki·bioRxiv·Oct 14, 2020
- NOXA/MCL-1 axis determines cell-death decision between apoptosis and pyroptosis and the inflammatory secretome of breast cancer cells treated with anti-mitotics.
A. Dumont, F. Gautier, … S. Barille-Nion·bioRxiv·Oct 6, 2023
- A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) Technology: Development of Targeted Apoptosis Initiators for Cancer Treatment .
Raghu S Pandurangi, R. Paulmurugan·bioRxiv·Dec 10, 2018
- Acute myeloid leukemia mitochondria hydrolyze ATP to resist chemotherapy
James T. Hagen, McLane M. Montgomery, … Kelsey H. Fisher‐Wellman·Science AdvancesPeer-reviewed·Apr 9, 2025
- Mitochondrial Matrix Protease ClpP Agonists inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis
Y. E. Greer, L. Hernandez, … S. Lipkowitz·bioRxiv·Mar 18, 2022